SCHEMBL1708946

SCHEMBL1708946

C/C=C/C[C@@H](C)[C@@H](O)[C@@H]1C(=O)N[C@H](C(C)C)C(=O)N(C)[C@H](CSCCN(CC)CC)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@H](C(C)C)C(=O)N(C)[C@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](CC(C)C)C(=O)N(C)[C@H](CC(C)C)C(=O)N(C)[C@H](C(C)C)C(=O)N1C

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPIA P62937 18/20 0.72
PPIB P23284 10/20 0.67
SLCO1B1 Q9Y6L6 4/20 0.67
ABCB1 P08183 4/20 0.67
ABCB11 O95342 2/20 0.67
ABCC2 Q92887 2/20 0.67
SLCO1B3 Q9NPD5 2/20 0.67
CYP3A4 P08684 2/20 0.67
CYP2C9 P11712 2/20 0.67
PPIF P30405 2/20 0.67
CYP2C19 P33261 2/20 0.67
MEN1 O00255 1/20 0.67
NPC1 O15118 1/20 0.67
ABCC3 O15438 1/20 0.67
GMNN O75496 1/20 0.67
USP2 O75604 1/20 0.67
SLCO2B1 O94956 1/20 0.67
LMNA P02545 1/20 0.67
POLB P06746 1/20 0.67
MAPT P10636 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16546034 1.00 PPIA (0.72) PPIAPPIBSLCO1B1ABCB1ABCB11
SCHEMBL1708944 0.96 PPIA (0.78) PPIAPPIBSLCO1B1ABCB1ABCB11
SCHEMBL15182917 0.96 PPIA (0.78) PPIAPPIBSLCO1B1ABCB1ABCB11
SCHEMBL16546031 0.96 PPIA (0.78) PPIAPPIBSLCO1B1ABCB1ABCB11
SCHEMBL15182919 0.96 PPIA (0.78) PPIAPPIBSLCO1B1ABCB1ABCB11
SCHEMBL19861427 0.96 PPIA (0.77) PPIAPPIBSLCO1B1ABCB1ABCB11
SCHEMBL15183399 0.96 PPIA (0.77) PPIAPPIBSLCO1B1ABCB1ABCB11
SCHEMBL15183393 0.93 PPIA (0.74) PPIAPPIBSLCO1B1ABCB1ABCB11
SCHEMBL18230925 0.93 PPIA (0.70) PPIAPPIBSLCO1B1ABCB1ABCB11
SCHEMBL16546038 0.93 PPIA (0.70) PPIAPPIBSLCO1B1ABCB1ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9493511-B2 Cyclosporin analogs ALLERGAN, INC. (US) 2016-11-15 US disclosed
US-20120088734-A1 Cyclosporin Analogs ALLERGAN, INC. (US) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088734-A1 Cyclosporin Analogs CHP1, TSLP, PPP3R1 PPIA 202/4885PPIB 149/4885SLCO1B1 1324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.